Oversold

LLY

Valuation76/ 100
Cash flow & growth82/ 100
Upside potential77/ 100
Risk potential19/ 100

LLY's valuation is historically cheap, fundamentals are above averages and forward estimates point to improving growth and profitability.

Score change since last week

The score rose 1 point, mainly due to valuation and price changes. Price fell 2.1%, from $1174.61 to $1149.36. Reported EPS was unchanged, so the lower price improved valuation support.

Valuation and price changes added 0.3 points. The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Valuation

Historical cheapness: current PE is 37.4× versus the full-history median of 48.9× shown in the valuation table, producing 67.5/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 75.6/100. The model applies a 34.8% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 51.8× (18-month half-life). The favorable scenario uses 44.4× PE and $43.2 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are strong. Over the past year: revenue +49.6%, earnings +94.8%, operating margin +1 percentage points. Free cash flow is 25.2% of revenue. The business score is 82.2/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Stronger earnings and valuation could support a higher share price.

Our favorable case uses $43.23 of EPS and a 44.4× PE, suggesting a share price of about $1917.95. Valuation history and outlook inform the PE.

The displayed favorable scenario is 71.9% upside, or about $1917.89.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $26.12 of EPS and a 34.8× PE, suggesting a share price of about $907.73 — 19% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

LLY vs Historical averages

MetricCurrentAverageRelative
PE37x57x35% lower
PE percentile305040% lower
EPS$29.80$9.50214% higher
FCF$20.1B$3.2B525% higher
Loading historical comparisons…

LLY’s earnings and cash flow are above their historical averages, while its earnings multiple is lower.

LLY Forward outlook

MetricOutlook
Forward valuationStrongly improving
Forward earningsStrong growth
Forward revenueGrowth
Forward profitabilityExpanding
Analyst coverageModerate
Estimate dispersionModerate

LLY’s outlook is generally improving, with growth expectations supporting the valuation case.

LLY PE Valuation

Loading pe valuation table…

This table applies LLY's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

LLY Earnings Per Share

Loading earnings per share…

This chart tracks LLY's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

LLY Quarterly Revenue

Loading quarterly revenue…

This chart tracks LLY's quarterly revenue over time and shows how sales are changing from year to year.

LLY Free Cash Flow

Loading free cash flow…

This chart tracks LLY's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

LLY Total Shares

Loading shares over time…

This chart tracks changes in LLY's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

LLY Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

LLY PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares LLY's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

LLY Weekly Price

Loading weekly price…

This chart uses LLY's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

LLY Weekly Moving Averages

Loading weekly moving averages…

This chart compares LLY's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

LLY Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.

MMED

ValuationN/A
Cash flow & growthN/A
Upside potentialN/A
Risk potentialN/A

Valuation

The valuation score compares today’s PE with recent history and similar earnings periods. Stronger growth supports a higher valuation; weaker growth lowers it. Earnings that are difficult to compare receive less weight.

Cash flow & growth

The business score reflects revenue and earnings growth, profit margins and free cash flow. Recent results show whether the business is improving or weakening. Measures must fit the business; incomplete or older data receives less weight.

Favorable scenario

Reliable data is insufficient to calculate upside.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Reliable data is insufficient to calculate downside.

This is a scenario based on our model, not a forecast or probability.

MMED vs Historical averages

MetricCurrentAverageRelative
Loading historical comparisons…

MMED Forward outlook

MetricOutlook
Forward valuation--
Forward earnings--
Forward revenueGrowth
Forward profitabilityStrongly expanding
Analyst coverageModerate
Estimate dispersionWide

MMED’s available outlook is mixed, though analysts differ widely on the estimates.

MMED PE Valuation

Loading pe valuation table…

This table applies MMED's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

MMED Earnings Per Share

Loading earnings per share…

This chart tracks MMED's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

MMED Quarterly Revenue

Loading quarterly revenue…

This chart tracks MMED's quarterly revenue over time and shows how sales are changing from year to year.

MMED Free Cash Flow

Loading free cash flow…

This chart tracks MMED's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

MMED Total Shares

Loading shares over time…

This chart tracks changes in MMED's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

MMED Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

MMED PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares MMED's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

MMED Weekly Price

Loading weekly price…

This chart uses MMED's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

MMED Weekly Moving Averages

Loading weekly moving averages…

This chart compares MMED's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

MMED Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.